Literature DB >> 15899801

Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein.

Ji-Hyun Chung1, Margaret E Ginn-Pease, Charis Eng.   

Abstract

Although phosphatase and tensin homologue deleted on chromosome 10 (PTEN) localization in the nucleus and cytoplasm is established, the mechanism is unknown. PTEN is a tumor suppressor phosphatase that causes cell cycle arrest and/or apoptosis. Nuclear-cytoplasmic compartmentalization may be a novel mechanism in regulating these events. PTEN does not contain a traditional nuclear localization sequence (NLS); however, we identified putative NLS-like sequences, which we analyzed by site-directed mutagenesis and localization studies in MCF-7 cells. Two double site mutations exhibited nuclear localization defects. Furthermore, unlike wild-type PTEN, double NLS mutant PTEN did not interact with major vault protein (MVP), a previously hypothesized nuclear-cytoplasmic transport protein. We conclude that these two NLS-like sequences are required for PTEN nuclear import that is mediated by MVP. Further, we show that this MVP-mediated nuclear import is independent of PTEN phosphorylation and of the lipid and protein phosphatase activities of PTEN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899801     DOI: 10.1158/0008-5472.CAN-05-0124

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  61 in total

1.  Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs.

Authors:  Anabel Gil; Amparo Andrés-Pons; Elena Fernández; Miguel Valiente; Josema Torres; Javier Cervera; Rafael Pulido
Journal:  Mol Biol Cell       Date:  2006-06-28       Impact factor: 4.138

2.  A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer.

Authors:  Mikael Herlevsen; Gary Oxford; Celeste Ptak; Jeffrey Shabanowitz; Donald F Hunt; Mark Conaway; Dan Theodorescu
Journal:  Biochem Biophys Res Commun       Date:  2006-11-21       Impact factor: 3.575

3.  Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.

Authors:  L A Henríquez-Hernández; A Valenciano; P Foro-Arnalot; M J Álvarez-Cubero; J M Cozar; J F Suárez-Novo; M Castells-Esteve; P Fernández-Gonzalo; B De-Paula-Carranza; M Ferrer; F Guedea; G Sancho-Pardo; J Craven-Bartle; M J Ortiz-Gordillo; P Cabrera-Roldán; J I Rodríguez-Melcón; E Herrera-Ramos; C Rodríguez-Gallego; P C Lara
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-12       Impact factor: 5.554

Review 4.  PTEN in DNA damage repair.

Authors:  Mei Ming; Yu-Ying He
Journal:  Cancer Lett       Date:  2012-01-18       Impact factor: 8.679

5.  Major Vault Protein, a Candidate Gene in 16p11.2 Microdeletion Syndrome, Is Required for the Homeostatic Regulation of Visual Cortical Plasticity.

Authors:  Jacque P K Ip; Ikue Nagakura; Jeremy Petravicz; Keji Li; Erik A C Wiemer; Mriganka Sur
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

Review 6.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

Review 7.  Oncogenic PTEN functions and models in T-cell malignancies.

Authors:  M Tesio; A Trinquand; E Macintyre; V Asnafi
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

8.  Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.

Authors:  Martina P Pasillas; Sarah Shields; Rebecca Reilly; Jan Strnadel; Christian Behl; Robin Park; John R Yates; Richard Klemke; Steven L Gonias; Judith A Coppinger
Journal:  Mol Cell Proteomics       Date:  2014-07-05       Impact factor: 5.911

9.  PTEN inhibits BMI1 function independently of its phosphatase activity.

Authors:  Catherine Fan; Lizhi He; Anil Kapoor; Adrian P Rybak; Jason De Melo; Jean-Claude Cutz; Damu Tang
Journal:  Mol Cancer       Date:  2009-11-10       Impact factor: 27.401

10.  Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.

Authors:  Glenn P Lobo; Kristin A Waite; Sarah M Planchon; Todd Romigh; Najah T Nassif; Charis Eng
Journal:  Hum Mol Genet       Date:  2009-05-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.